Targovax's Grant

Targovax raised a round of funding on December 01, 2010. Investors include Innovation Norway.

Targovax is an Oslo-area based global biotechnology company, dedicated to the design and development of immunotherapy vaccines for patients with RAS-mutated cancers.…

Articles about Targovax's Grant: